Aoke Botai Biotech , established in 2002, is a leading developer, manufacturer, and marketer of monoclonal antibodies and antigens for the In-Vitro Diagnostic (IVD) industry. As an ISO 13485:2016 and ISO 9001:2016 certified company, we maintain the highest standards of quality and operational excellence.
We take pride in being the pioneering organization in China to develop antibody pairs for HbeAg detection. Our extensive portfolio includes over 50 high-quality monoclonal antibody projects and more than 40 high-quality antigen projects, with this number continuously expanding year after year.
With a dedicated team of experienced researchers, a state-of-the-art 4,000-square-meter production facility, we are fully equipped to ensure both dependable quality and a consistent supply capacity.Our products have garnered recognition and approval across diverse applications, including tumor markers, cardiovascular health, inflammation, infectious diseases, hormone analysis, and kidney markers, where they have consistently demonstrated performance on par with esteemed international benchmark brands.
In 2021, we expanded our capabilities with the launch of the colloidal gold and fluorescent chromatography board production line to cater to global customer demands. We are committed to delivering excellence and aim to establish a world-class supply base for diagnostic reagent raw materials.
中文
